What drives successful small-molecule drug discovery today

Small-molecule discovery is evolving beyond traditional approaches, with AI, expanded chemical space, and emerging modalities reshaping how candidates are designed and optimized.

Integrated Design–Make–Test–Decide workflows help connect chemistry, biology, and data to accelerate better candidate decisions.

key points:

• Explore chemical space with AI, virtual screening, and HTS.
• Connect molecular design with experimental results and SAR analysis.
• Use AI-assisted insights to prioritize promising drug candidates.